[company_age]4.0[/company_age][employees]2-10 employees[/employees][funding]Seed[/funding][description]PROSION Therapeutics is a German biotech company that specializes in developing drugs for hard-to-treat diseases, particularly aggressive forms of cancer. The company's proprietary platform technology utilizes LEGO-like chemical building blocks to create new and effective drugs that target previously undruggable protein-protein interactions. This technology focuses on mimicking the complex 3D structure of PRMs (Proline-Rich Motifs), which are essential drivers of cellular malfunctions leading to various diseases. PROSION's unique approach addresses the challenge of targeting these PRMs, which have previously been considered undruggable due to their unique helical structure. PROSION Therapeutics is committed to improving the lives of patients by developing innovative and effective therapies.[/description][ps]Drug development for hard-to-treat diseases, particularly aggressive forms of cancer.[/ps]